Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
暂无分享,去创建一个
[1] F. Robertson,et al. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. , 1999, Cancer letters.
[2] E. Hawk,et al. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. , 2000, Cancer research.
[3] B. Levin,et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.
[4] D. Dixon,et al. Transforming Growth Factor-β1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA* , 2000, The Journal of Biological Chemistry.
[5] D. A. Dixon,et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. , 2001, The Journal of clinical investigation.
[6] J. Morrow,et al. Regulation of Constitutive Cyclooxygenase-2 Expression in Colon Carcinoma Cells* , 2000, The Journal of Biological Chemistry.
[7] F. Marks,et al. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] Bruno C. Hancock,et al. Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.
[9] J. Bolognese,et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. , 1999, JAMA.
[10] K. Seibert,et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. , 2000, Cancer research.
[11] G. FitzGerald,et al. The coxibs, selective inhibitors of cyclooxygenase-2. , 2001, The New England journal of medicine.
[12] K. Seibert,et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. , 1998, Cancer research.
[13] R. Kurumbail,et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.
[14] R. Langenbach,et al. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. , 2000, Cancer research.
[15] A. Castonguay,et al. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. , 1998, Cancer research.
[16] M. Sliwkowski,et al. Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. , 2001, Gastroenterology.
[17] C. Gomer,et al. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. , 2002, Cancer research.
[18] A. Sorokin,et al. Regulation of MDR-1 (P-glycoprotein) by Cyclooxygenase-2* , 2002, The Journal of Biological Chemistry.
[19] Fan Zhang,et al. Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2* , 1998, The Journal of Biological Chemistry.
[20] Y. Konishi,et al. Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide. , 2001, Cancer research.
[21] Thomas M. McIntyre,et al. Post-transcriptional Control of Cyclooxygenase-2 Gene Expression , 2000, The Journal of Biological Chemistry.
[22] L. Norton,et al. Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer , 2002, The Journal of Biological Chemistry.
[23] D. Dunson,et al. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. , 2002, Cancer research.
[24] K. Seibert,et al. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. , 2000, Cancer research.
[25] T. Tsuruo,et al. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522 , 1999, British Journal of Cancer.
[26] P. Tofilon,et al. Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme , 1999 .
[27] Li Zhu,et al. Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis1 , 2000, The Journal of Immunology.
[28] T. Hla,et al. Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[29] B. Levine,et al. Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11. , 2002, Cancer research.
[30] J. Isola,et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. , 2002, Cancer research.
[31] I. Gibbs,et al. Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells. , 2000, International journal of radiation oncology, biology, physics.
[32] R. Garavito,et al. Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.
[33] K. Seibert,et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet light–induced skin carcinogenesis , 1999, Molecular carcinogenesis.
[34] V. Steele,et al. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. , 2000, Cancer research.
[35] S. Ghosh,et al. Transcriptional Activation of the Cyclooxygenase-2 Gene in Endotoxin-treated RAW 264.7 Macrophages* , 2000, The Journal of Biological Chemistry.
[36] W. White,et al. Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. , 2002, The American journal of cardiology.
[37] Kenneth K Wang,et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. , 2002, Gastroenterology.
[38] Y. Bang,et al. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells. , 2001, Cancer research.
[39] K. Subbaramaiah,et al. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. , 2001, The Journal of biological chemistry.
[40] H. Sheng,et al. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. , 2000, Cancer research.
[41] Rajnish A. Gupta,et al. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 , 2001, Nature Reviews Cancer.
[42] H. Sheng,et al. Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. , 2000, Neoplasia.
[43] N. Altorki,et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. , 2001, The Lancet. Oncology.
[44] A. Dannenberg,et al. National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms. , 2002, Neoplasia.
[45] Chemoprevention of intestinal polyposis in the APCΔ716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor , 2000 .
[46] K. Matsuo,et al. Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[47] C. Mendelson,et al. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. , 1996, Endocrinology.
[48] R. Langenbach,et al. Malignant Transformation and Antineoplastic Actions of Nonsteroidal Antiinflammatory Drugs (Nsaids) on Cyclooxygenase-Null Embryo Fibroblasts , 1999, The Journal of experimental medicine.
[49] E. Topol,et al. Risk of cardiovascular events associated with selective COX-2 inhibitors. , 2001, JAMA.
[50] R. Makuch,et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.
[51] P. Cole,et al. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. , 2002, Cancer research.
[52] Aubrey R. Morrison,et al. The 3′-Untranslated Region of Murine Cyclooxygenase-2 Contains Multiple Regulatory Elements That Alter Message Stability and Translational Efficiency* , 2001, The Journal of Biological Chemistry.
[53] L. Norton,et al. Microtubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2 , 2000, The Journal of Biological Chemistry.
[54] Michael J Thun,et al. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. , 2002, Journal of the National Cancer Institute.
[55] N. Altorki,et al. Inhibition of Cyclooxygenase-2 Gene Expression by p53* , 1999, The Journal of Biological Chemistry.
[56] F. Chan,et al. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer , 2001, British Journal of Cancer.
[57] K. Subbaramaiah,et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. , 1996, Cancer research.
[58] P. Taylor,et al. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible? , 2001, Anticancer research.
[59] K. Kawakami,et al. A Selective Cyclooxygenase‐2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma Cells , 1999, Japanese journal of cancer research : Gann.
[60] K. Seibert,et al. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. , 2000, Cancer research.
[61] B. Levin,et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis , 2002, Gut.